Richardson Capital Management »

Cytokinetics shares owned by Richardson Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Richardson Capital Management from 13F filings

Historical chart of Richardson Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Richardson Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Richardson Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.5k 38 65.92

More positions owned by Richardson Capital Management

Schwab US Large-Cap ETF Us Lrg Cap Etf (SCHX)
Schwab US Large-Cap Growth ETF Us Lcap Gr Etf (SCHG)
Schwab Fundamental US Large Company ETF Fundamental Us L (FNDX)
Vanguard 500 ETF S&p 500 Etf Shs (VOO)
iShares Core S&P Mid-Cap ETF Core S&p Mcp Etf (IJH)
Schwab US Dividend Equity ETF Us Dividend Eq (SCHD)
NVIDIA Corporation (NVDA)
Dimensional US Small Cap Value ETF Us Small Cap Val (DFSV)
Matthews EM Discovery Active ETF Emerging Mkt Dis (MEMS)
Schwab US Mid-Cap ETF Us Mid-cap Etf (SCHM)
PGIM Ultra Short Bond ETF Pgim Ultra Sh Bd (PULS)
Invesco QQQ Trust ETF Unit Ser 1 (QQQ)
Schwab 1000 Index ETF 1000 Index Etf (SCHK)
iShares Russell Mid-Cap Growth ETF Rus Md Cp Gr Etf (IWP)
Vanguard Growth ETF Growth Etf (VUG)

View all positions for Richardson Capital Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics